Form 4: TransDigm CFO Executes Pre-Arranged Stock Option Exercise and Share Sale

TransDigm Group Inc.'s Chief Financial Officer, Sarah Wynne, completed a pre-scheduled transaction on June 13, 2025, involving the exercise of stock options and the subsequent sale of common shares under a Rule 10b5-1 plan.

Summary

• Sarah Wynne, the Chief Financial Officer of TransDigm Group Inc. (TDG), reported transactions on June 13, 2025.
• She exercised stock options to acquire 1,800 shares of TransDigm common stock at an exercise price of $559.78 per share.
• Concurrently, she sold 1,800 shares of TransDigm common stock at a price of $1,450 per share.
• These transactions were executed under a Rule 10b5-1 pre-arranged trading plan.
• Following these transactions, Ms. Wynne directly beneficially owns 3,400 shares of TransDigm common stock.
• An additional 10 shares are indirectly beneficially owned by her husband.
• She also retains beneficial ownership of 5,000 derivative securities (stock options) after the reported transactions.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The transaction is a routine insider activity for liquidity/diversification, executed under a transparent 10b5-1 plan. The significant profit realized from the option exercise is a positive for the executive.

Positives

• The transactions were conducted under a Rule 10b5-1 plan, which indicates a pre-scheduled trade and enhances transparency, mitigating concerns about opportunistic insider trading.
• The sale price of $1,450 per share is significantly higher than the option exercise price of $559.78, demonstrating a substantial realized gain for the executive on the exercised shares.

Negatives

• The sale of 1,800 shares by a key executive, even under a 10b5-1 plan, represents a reduction in direct shareholding, which some investors might interpret as a slight negative, though it's a common practice for liquidity or diversification.

Future Outlook

This Form 4 filing is a disclosure of insider transactions and does not contain any forward-looking statements or guidance regarding TransDigm Group Inc.'s future performance or business outlook.

Industry Context

This filing reports a routine insider transaction, common across all industries for executives managing their compensation and personal finances. It does not provide broader industry context or trends, focusing solely on the individual executive's stock activity.

Stakeholder Impact

• Shareholders: The sale of shares by a CFO, while under a pre-arranged plan, might be viewed neutrally or with slight caution by some, but the transparency of the 10b5-1 plan mitigates negative interpretations. The significant profit from the option exercise highlights the value of executive compensation.
• Employees, Customers, Suppliers, Creditors: This filing has no direct or material impact on these stakeholders as it pertains solely to an executive's personal stock transactions.

Key Dates

Keywords

TransDigm Group, TDG, SEC Form 4, Insider Trading, Stock Options, Share Sale, 10b5-1 Plan, Chief Financial Officer, Sarah Wynne, Beneficial Ownership